Skip to content

The therapeutic effects of Intensity Focused Ultrasound (HIFU) for different types of adenomyosis

The therapeutic effects of Intensity Focused Ultrasound (HIFU) for the different types of adenomyosis

Status
Recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000037087
Enrollment
Unknown
Registered
2020-08-26
Start date
2020-10-01
Completion date
Unknown
Last updated
2020-10-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adenomyosis

Interventions

6:HIFU treatment

Sponsors

Shanghai First Maternity and Infant Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 50 Years

Inclusion criteria

Inclusion criteria: 1. Patients with clinical symptoms of progressive dysmenorrhea and / or menorrhagia have no difficulty in sexual intercourse; 2. Patients with larger uterus and irregular spherical shape in gynecological examination; 3. In patients with enlarged uterus found by transvaginal ultrasound, the echo of myometrium is uneven, the myometrium is not clear, and the size of the lesion is not clear; 4. The patients who did not use steroid hormone or GnRHa 6 months before treatment had no contraindications such as GnRH-a and IUD; 5. Patients who refused open or laparoscopic surgery; 6. Patients with normal liver and kidney function.

Exclusion criteria

Exclusion criteria: 1. Pregnant, lactating or menstrual patients; 2. Patients with acute pelvic inflammatory disease; 3. Patients with suspected gynecological malignancies; 4. Patients with history of radiotherapy; 5. Patients who are unable to communicate with doctors during the operation.

Design outcomes

Secondary

MeasureTime frame
CA125;hemogelobin;

Primary

MeasureTime frame
uterine volume;Lesion volume;mentrual volume;VAS;

Countries

China

Contacts

Public ContactAixingzi·Aili

Shanghai First Maternal and Infant Health Care Hospital

1819483078@qq.com+86 18017211589

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026